The Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of Obesity

الملخص EN

The global obesity epidemic, dubbed “globesity” by the World Health Organisation, is a pressing public health issue.

The aetiology of obesity is multifactorial incorporating both genetic and environmental factors.

Recently, epidemiological studies have observed an association between microbes and obesity.

Obesity-promoting microbiome and resultant gut barrier disintegration have been implicated as key factors facilitating metabolic endotoxaemia.

This is an influx of bacterial endotoxins into the systemic circulation, believed to underpin obesity pathogenesis.

Adipocyte dysfunction and subsequent adipokine secretion characterised by low grade inflammation, were conventionally attributed to persistent hyperlipidaemia.

They were thought of as pivotal in perpetuating obesity.

It is now debated whether infection and endotoxaemia are also implicated in initiating and perpetuating low grade inflammation.

The fact that obesity has a prevalence of over 600 million and serves as a risk factor for chronic diseases including cardiovascular disease and type 2 diabetes mellitus is testament to the importance of exploring the role of microbes in obesity pathobiology.

It is on this basis that Massachusetts General Hospital is sponsoring the Faecal Microbiota Transplant for Obesity and Metabolism clinical trial, to study the impact of microbiome composition on weight.

The association of microbes with obesity, namely, adenovirus infection and metabolic endotoxaemia, is reviewed.